GMMs such as Trp metabolites, BA metabolites and SCFAs have widely effects on the function and differentiation of immune cells such as CD8 and NK cells, which are involved in NKG2A: HLA-E ICB immunotherapy against tumor. Here, KLRC1 is linked to neoplasm.